Horses, donkeys and zebras have adaptations that break normal genomic rules
A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
EMBO Press11h
HAND1 level controls the specification of multipotent cardiac and extraembryonic progenitors from human pluripotent stem cells
How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...
Zacks Investment Research on MSN7h
Intellia Focuses on Pipeline Development Amid Stiff Competition
Intellia Therapeutics, Inc. NTLA is developing its lead CRISPR-based, in vivo genome-editing candidate, nexiguran ziclumeran (nex-z, formerly known as NTLA-2001) for the treatment of transthyretin ...
C&EN4h
As research funding dries up for US science, few alternatives appear
Budget cuts, delays to grant reviews, and layoffs of federal workers at agencies like the NIH and the National Science Foundation have affected nearly every research organization in the US. If ...